Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05906056
Status:
RECRUITING
Last Update Posted:
2023-06-22
First Post:
2023-05-08
Brief Title:
Continuous Passive Motion Versus Heterotopic Ossification
Sponsor:
University of Ioannina
Organization:
University of Ioannina
Study Overview
Official Title:
Program of Continuous Passive Motion Exercises Against Heterotopic Ossification
Status:
RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CPMversusHO
Brief Summary:
The investigators hypothesize that Heterotopic Ossification HO formation can be suppressed if the application of a Continuous Passive Motion CPM device can be performed for a substantial amount of time The investigators will use the following study design a pilot study with 10 ICU patients receiving CPM and 10 matched cases which will follow a conventional physiotherapy program at the time of the conduction of the study The comparison between the treatment and referent groups of the outcomes will prove the prophylactic power of CPM against HO
Detailed Description:
The aim of this study is to formally evaluate whether the investigators can indeed prevent HO by the timely and painless use of CPM in neurogenic intensive care unit ICU patients with stabilized medical conditions suffering from neurological insults either traumatic brain injury TBI stroke or Spinal Cord Injury SCI The investigators hypothesize that HO formation can be suppressed if CPM can be performed for a substantial amount of time The investigators will perform a pilot study with 10 ICU patients receiving CPM and 10 matched cases which will follow a conventional physiotherapy program at the time of the conduction of the study The primary outcomes will be the CT appearance of HO in the hip or knee joint and the degree of ROM limitation in the given joint at baseline and at the end of the clinical trial A secondary outcome that will be measured will be the Glasgow Coma Scale GCS at the beginning and at the end of the CPM program The comparison between the treatment and referent groups in terms of these outcomes will prove the prophylactic power of CPM against HO
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None